UWHC logo

Preoperative Cardiac Evaluation for
Noncardiac Surgery: Clinical Risk Predictors

(File last saved:11/4/04)

PAC Home | Cardiac Eval Start


Adapted from: American College of Cardiology/American Heart Association Task Force on Practice Guidelines
(Committee on Preoperative Cardiovascular Evaluation for Noncardiac Surgery). Executive Summary of the ACC/AHA Task Force Report
(2002 Update):
Guidelines for Perioperative Cardiovascular Evaluation for Noncardiac Surgery.

Anesth Analg 2002;94:1052-64


Steps: Major Clinical Predictors

Clarifications

Unstable coronary syndromes:

  • Acute (≤ 7 days) or Recent (> 7 but ≤ 30 days) MI with evidence of important ischemia by clinical symptoms or noninvasive study.
  • Unstable or severe angina (class III, IV). May include stable angina in patients who are extremely sedentary.

Significant arrhythmias:

  • High-grade AV block
  • Symptomatic ventricular arrythmias with underlying heart disease
  • Supraventricular arrythmia with uncontrolled ventricular rate
  • Major Clinical Predictors: Does the patient have an unstable coronary syndrome or a major clinical predictor of risk? When elective noncardiac surgery is being considered, the presence of unstable coronary disease, decompensated HF, symptomatic arrhythmias, and/or severe valvular heart disease usually leads to cancellation or delay of surgery until the problem has been identified and treated.

[top] | PAAC Home | Cardiac Eval Start


Steps: Intermediate Clinical Predictors

Clarifications

None
  • Intermediate Clinical Predictors: Does the patient have intermediate clinical predictors of risk? The presence or absence of prior MI by history or ECG, angina pectoris, compensated or prior HF, preoperative creatinine greater than or equal to 2 mg per deciliter, and/or diabetes mellitus helps to further stratify clinical risk for perioperative coronary events. Consideration of functional capacity and level of surgery-specific risk allows a rational approach to identify patients most likely to benefit from further noninvasive testing.
  • Testing: Patients without major but with intermediate predictors of clinical risk and moderate or excellent functional capacity can generally undergo intermediate-risk surgery with little likelihood of perioperative death or MI. Conversely, further noninvasive testing is often considered for patients with poor functional capacity or moderate functional capacity but higher-risk surgery, especially for patients with 2 or more intermediate predictors of risk.

[top] | PAAC Home | Cardiac Eval Start


Steps: Minor Clinical Predictors

Clarifications

Abnormal ECG:

  • LVH, LBBB, ST-T abnormalities

Rythm other than sinus:

  • e.g.,atrial fibrillation

Low functional capacity:

  • e.g., "inability to climb 1 flight of stairs with a grocery bag"

  • "Minor" Clinical Predictors: Noncardiac surgery is generally safe for patients with neither major nor intermediate predictors of clinical risk and moderate or excellent functional capacity (4 METs or greater). Additional testing may be considered on an individual basis for patients without clinical markers but with poor functional capacity who are facing higher-risk operations, particularly those with several minor clinical predictors of risk who are scheduled to undergo vascular surgery.
  • Testing: The results of noninvasive testing can be used to determine the need for additional preoperative testing and treatment. In some patients with documented CAD, the risk of coronary intervention or corrective cardiac surgery may approach or even exceed the risk of the proposed noncardiac surgery. This approach may be appropriate, however, if it significantly improves the patient’s long-term prognosis.

[top] | PAAC Home | Cardiac Eval Start